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Diet is important in the prevention of CVD, and it has been suggested that a diet high in MUFA is more cardioprotective than a low-fat diet.
We hypothesised that the thrombotic risk profile is improved most favourably by a high-MUFA diet compared with a low-fat diet. This was
tested in a parallel randomised intervention trial on overweight individuals (aged 28·2 (SD 4·6) years) randomly assigned to a diet providing a
moderate amount of fat (35–45 % of energy; .20 % of fat as MUFA) (MUFA diet; n 39), to a low-fat (LF; 20–30 % of energy) diet (n 43),
or to a control diet (35 % of energy as fat; n 24) for 6 months after a weight loss of about 10 %. Protein constituted 10–20 % of energy in all
three diets. All foods were provided free of charge from a purpose-built supermarket. Fasting blood samples were collected before and after
intervention and analysed for factor VII coagulant activity (FVII:c), fibrinogen, prothrombin fragment 1 þ 2 (F1 þ 2), D-dimer and plasminogen
activator inhibitor (PAI). The fibrinogen concentration was significantly lowered by the LF diet, but not by the MUFA diet. Changes in fibrinogen
differed significantly between diet groups. BMI and PAI concentration increased and D-dimer concentrations were reduced irrespective of the diets.
No changes were observed for FVII:c and F1 þ 2. Our findings suggest that in overweight subjects after weight loss the thrombotic risk profile
is improved most favourably by the LF diet compared with the MUFA diet based on the reduction in fibrinogen concentrations.
Diet intervention: Long-term studies: MUFA: Randomised studies: Thrombotic risk
Diet is an important factor in the prevention of CVD as
demonstrated in The Nurses’ Health Study, a large prospective
study in 121 700 initially healthy nurses(1), in which high
intakes of SFA, trans-fatty acids and carbohydrates with a
high glycaemic index (GI) were associated with increased
CVD risk(1,2), and high intakes of MUFA and PUFA were
associated with reduced CVD risk(1).
Recently, an alternative dietary pyramid was introduced in the
USA by one of the Nurses’ Health Study investigators(3). The
main difference between Willett’s new pyramid and the US
Department of Agriculture (USDA) 2004 Food Pyramid is that
the new pyramid has no restrictions on fat as long as it is of
vegetable origin, and the carbohydrates should have a high
content of whole grains. Such a diet is assumed to have a more
cardioprotective effect than a diet following the USDA 2004
Food Pyramid. Although the Nurses’ Health Study is a very
large and well-designed study, the study conclusions should
not alone be used to change the established dietary recommen-
dations without also having results from long-term controlled
comparisons with existing dietary recommendations. Because
a controlled randomised dietary study in healthy individuals
with CVD as the end point will be practically infeasible, CVD
risk markers can be studied as an alternative.
Thrombosis is a key factor in CVD as illustrated by the
association between plasma concentrations of haemostatic
variables and the risk of CVD in prospective studies. Associa-
tions have been observed for fibrinogen(4), the fibrin degra-
dation product D-dimer(5), plasminogen activator inhibitor
(PAI)-1(6,7), and factor VII coagulant activity (FVII:c)(8).
A large number of studies have reported an effect of specific
dietary components on these CVD risk markers, for example,
effects of dietary fat on factor VII (FVII)(9 – 11), but only a
few studies have looked at the long-term effects of complex
dietary changes(12 – 14).
*Corresponding author: Dr Else-Marie Bladbjerg, fax þ45 79182430, email ebladbjerg@health.sdu.dk
Abbreviations: F1 þ 2, prothrombin fragment 1 þ 2; FVII, factor VII; FVII:c, factor VII coagulant activity; GI, glycaemic index; LF, low-fat; PAI, plasminogen
activator inhibitor.
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The aim of the present study was to compare the long-term
effect on haemostatic variables of three different ad libitum
diets in a 6-month strictly controlled dietary intervention in
healthy obese subjects after weight loss. The diets compared
were Willett’s new Healthy Eating Pyramid (high in MUFA
and low in GI), the Official Nordic Dietary Guidelines
(low in fat and medium in GI) and the average Danish diet
(high in SFA and high in GI). We hypothesised that the
thrombotic risk profile will be improved most favourably by
the diet high in MUFA and low in GI.
Experimental methods
Study population
The dietary intervention, Mono Unsaturated Fatty acids in
Obesity (MUFObes), was conducted at the Department of
Human Nutrition, Faculty of Life Sciences, University of
Copenhagen (Frederiksberg, Denmark) and has been described
in detail elsewhere(15,16). Briefly, 131 obese individuals were
randomly assigned to one of three diets. The inclusion criteria
were aged 18–35 years, BMI 28–36 kg/m2, body weight fluc-
tuations of , 3 kg over the previous 2 months, and a non-
smoking status. Subjects were healthy and took no regular
medicine other than contraceptive pills. All subjects gave
oral and written informed consent, and the Ethics Committee
of the Municipalities of Copenhagen and Frederiksberg
approved the study according to the Helsinki Declaration.
The trial was registered at clinicaltrials.gov as NCT00274729.
The population characteristics at study entry are described
in Table 1. For various reasons, twenty-five participants
dropped out during the intervention period leaving thirty-
nine participants in the MUFA group, forty-three participants
in the low-fat (LF) group, and twenty-four participants in the
control group(15).
Study design
The study was a parallel intervention trial comparing the
effect of three diets on body weight and cardiovascular risk
after 6 months of intervention. The study design is presented
in Fig. 1 and has been described in detail previously(15).
After an initial 8-week low-energy diet, only subjects who
lost . 8 % of their body weight were randomised to one of
the experimental diets. After randomisation, the participants
completed a 3-week standardisation period (weight stabilisa-
tion and adaptation to the supermarket model) eating a diet
resembling the average Danish diet, corresponding to the con-
trol diet. The 6-month intervention study started in May 2004
and ended in November 2004.
Experimental diets
The 6-month dietary intervention was based on an ad libitum
design in order to mimic free-living conditions and to test
the real appetite regulation of the diets. There were three
prescribed diets. (1) The MUFA diet was designed to be
moderate in fat (35–45 % of energy), high in MUFA
(.20 % of energy) and moderate in low-GI carbohydrates
(40–50 % of energy) with a high content of vegetable oils,
whole-grain food, nuts and legumes. (2) The LF diet was
low in fat (20–30 % of energy) and high in mixed-GI carbo-
hydrates (55–65 % of energy). (3) The control diet corres-
ponded to the average Danish diet and was moderate in
fat (30–40 % of energy), high in SFA (.15 % of energy),
moderate in high-GI carbohydrates (45–55 % of energy) and
low in fibre (,3 % of energy). All three diets were moderate
in protein (10–20 % of energy). Foods recommended for the
three dietary groups have previously been described(15). The
actual dietary composition (Table 2) was in accordance with
the prescribed dietary composition, and the biopsy content
of fatty acids (assessment of compliance) was in accordance
with the prescribed diets(15).
Supermarket foods, the computer program and shopping
sessions
To provide the subjects with all necessary foods and to
accomplish a total recording of the food consumed, a validated
supermarket model(17) was established at the department. The
supermarket foods, the computer program and the shopping
sessions have been described extensively elsewhere(15,16,18).
Throughout the 6-month intervention, the subjects obtained
all foods and beverages at the study supermarket, free of
charge, and they were instructed to consume only these foods.
Blood sampling
Venous blood samples were drawn after lying in a supine
position for 10 min after at least 10 h fasting, and 24 h
abstention from alcohol and strenuous physical activity.
Table 1. Population characteristics at study entry*
(Mean values and standard deviations)
High-MUFA
diet (n 54)
Low-fat diet
(n 51)
Control diet
(n 26)
Variable Mean SD Mean SD Mean SD
Age (years) 29·2 4·5 27·3 4·9 27·6 5·1
Sex (n)
Male 22 22 11
Female 32 29 15
Body weight (kg) 95·4 12·8 96·9 13·5 93·9 13·8
Height (m) 1·74 0·1 1·75 0·1 1·73 0·1
BMI (kg/m2) 31·4 2·7 31·6 2·7 31·3 2·5
* Measurements were made at screening before weight loss. Mean values for the
three diets were compared with an ANOVA. Sex was compared with the x2 test.
No significant differences existed between the groups at study entry.
Randomisation
end of LED
Study start Intervention start
6 months0 months
6 months dietary intervention period
Standardisation
period (2–3 weeks)
8 weeks LED
Fig. 1. Design of the Mono Unsaturated Fatty acids in Obesity (MUFObes)
study. LED, low-energy diet.
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Blood samples were collected with minimal stasis using
siliconised vacutainers and 21-gauge needles. First, 4·5 ml
blood were collected in 0·5 ml of 0·129 M-trisodium citrate at
room temperature for analyses of FVII, fibrinogen, D-dimer,
TAG and total cholesterol, and 4·5 ml blood were collected
in 0·5 ml of 0·129 M-trisodium citrate tubes on ice for analysis
of prothrombin fragment 1 þ 2 (F1 þ 2). Finally, 4·5 ml blood
were collected in Stabilyte Tubes (Biopool, Umea˚, Sweden)
for analysis of PAI antigen.
Tubes collected at room temperature were centrifuged at
208C for 20 min at 2000 g. Tubes for analysis of F1 þ 2 and
PAI were centrifuged at 48C for 20 min at 2000 g. Plasma
was pipetted into plastic vials and stored at 2708C.
Blood analyses
Plasma samples were rapidly thawed in a water-bath at 378C
and analysed in one series for each subject. Cholesterol
and TAGs were determined enzymically with a COBAS
INTEGRA (Roche, Mannheim, Germany). Plasma FVII:c
was measured in a one-stage clotting assay using rabbit
brain thromboplastin (Diagnostica Stago, Asnie`res, France).
Fibrinogen concentrations were measured by a nephelometric
method (Dade Behring, Marburg, Germany). A commercial
ELISA (Enzygnost-F1 þ 2; Dade Behring) was used to
measure concentrations of F1 þ 2. Rabbit anti-human
F1 þ 2 IgG was used as the first and second antibody.
Concentrations of D-dimer were measured by an immuno-
turbidimetric method (STA-Liatest D-DI; Diagnostica Stago).
PAI antigen was measured using an enzyme immunoassay
(Haemochrom Diagnostica, Frederiksberg, Denmark).
Statistics
The statistical analyses were done on completers only and
performed with the SPSS program (version 16.0; SPSS, Inc.,
Chicago, IL, USA). The distribution of the results for TAG,
D-dimer, PAI and F1 þ 2 was skewed and values were
logarithmically transformed before analysis. Fasting values
were compared between the three diets at the start of
intervention (0 months) and at the end of intervention
(6 months) using an ANOVA. When significant between-
diet effects were observed, post hoc analyses were performed
for pairwise analyses and adjusted for multiple comparisons
by the Bonferroni test.
To test for differences within groups, fasting values at
6 months were compared with fasting values at 0 months for
each of the three diets separately using a paired t test.
Furthermore, differences between diet groups in changes
from month 0 to 6 for all variables were analysed by a
univariate ANOVA using dietary group as a fixed factor and
baseline values, changes in BMI, and changes in total choles-
terol and TAG as covariates in order to adjust for possible
confounders. In the case of significance in the ANOVA,
pairwise analyses were performed.
Results are presented as mean values or geometric mean
values and standard deviations. P,0·05 was considered
statistically significant.
Results
We excluded seven study participants from the statistical
calculations due to concentrations of C-reactive protein
(CRP) . 10 mg/l (n 6), indicating an inflammatory condition,
or very high concentrations of intercellular adhesion molecule
(ICAM) (1434 ng/ml; n 1), signifying pronounced endothelial
cell dysfunction (results for CRP and ICAM will be published
separately). These seven participants were distributed with
three participants in the MUFA group, three participants in
the LF group, and one participant in the control group.
There were no significant differences in baseline values
(month 0) between the three experimental diets except for
significant difference in BMI between the MUFA diet and
the LF diet (Table 3). This difference persisted after
6 months (P,0·01), with significant differences also between
the MUFA diet and the control diet (P,0·05). No other
significant differences were observed after 6 months between
the three diets (Table 3).
When the effects of 6 months of intervention were analysed
within each dietary group, a significant increase in BMI and
Table 2. Actual nutrient composition of the experimental diets
(Mean values and 95 % confidence intervals)
High-MUFA diet (n 39) LF diet (n 43) Control diet (n 24)
Mean 95 % CI Mean 95 % CI Mean 95 % CI P ‡
Energy intake (MJ/d) 11·5 10·6, 12·4 10·5 9·7, 11·3 10·9 9·6, 12·3 0·27
Total fat (E%) 38·4***††† 37·9, 39·0 23·6*** 23·1, 24·1 32·1 31·4, 32·7 ,0·001
SFA (E%) 7·1***††† 6·9, 7·4 7·9*** 7·6, 8·3 15·1 14·7, 15·5 ,0·001
MUFA (E%) 20·2***††† 19·8, 20·6 8·4*** 8·1, 8·6 10·4 10·0, 10·8 ,0·001
PUFA (E%) 7·8***††† 7·6, 8·1 5·2*** 5·1, 5·4 4·0 3·7, 4·3 ,0·001
Carbohydrates (E%) 43·3***††† 42·7, 43·9 57·6*** 57·0, 58·2 49·8 49·2, 50·5 ,0·001
Fibre (E%) 3·8***††† 3·7, 4·0 3·7*** 3·5, 3·9 2·7 2·4, 2·9 ,0·001
Added sugar (E%) 5·4***††† 4·8, 5·9 7·2*** 6·4, 7·9 9·7 8·7, 10·7 ,0·001
Glycaemic index Low Moderate High
Protein (%) 15·3*† 14·9, 15·6 15·8 15·5, 16·2 15·9 15·4, 16·4 0·04
Alcohol (E%) 2·6 1·9, 3·3 2·6 2·0, 3·3 2·0 1·2, 2·8 0·43
LF, low-fat; E%, percentage of energy.
Mean value was significantly different from that for control: * P,0·05, *** P,0·001 (pairwise analyses).
Mean value was significantly different from that for LF: † P,0·05, ††† P,0·001 (pairwise analyses).
‡ Mean values for the three diets were compared with an ANOVA.
E.-M. Bladbjerg et al.1826
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PAI and a significant decrease in D-dimer was observed on
the MUFA diet. For the LF diet a significant increase in
BMI and PAI and a significant decrease in TAG, fibrinogen
and D-dimer were observed. For the control diet there was a
significant increase in BMI and PAI and a significant decrease
in fibrinogen and an almost significant decrease in D-dimer
(P¼0·056) and cholesterol (P¼0·059) (Table 3). No
significant changes were observed in FVII:c and F1 þ 2
(Table 3).
Significant differences between diet groups in changes from
month 0 to 6 were only observed for changes in fibrinogen
(P,0·05). Similar results were observed after adjustment for
baseline values, changes in BMI and changes in lipids
(P,0·05). This was due to significantly different fibrinogen
changes during 6 months between the MUFA diet
(D fibrinogen 0! 6 monthsMUFA ¼ 20·11 (SD 0·44) g/l)
and the LF diet (D fibrinogen 0! 6 monthsLF ¼ 20·38 (SD
0·48) g/l) (P,0·05) and between the LF diet and the control
diet (D fibrinogen 0! 6 monthsCONTROL ¼ 20·17 (SD 0·39)
g/l) (P,0·01), with the most pronounced fibrinogen reduction
on the LF diet (Fig. 2).
Discussion
In this weight-loss maintenance study, the fibrinogen
concentration was significantly lowered by the LF diet, and
not by the MUFA diet (Table 3). Changes in fibrinogen
concentrations during 6 months differed significantly between
diet groups, with the most pronounced fibrinogen reduction
on the LF diet (Fig. 2). Furthermore, we observed significant
increases in BMI and PAI concentration and significant
reductions in D-dimer concentrations irrespective of the
experimental diet.
The observed effects on fibrinogen suggest a less favourable
cardiovascular effect of the MUFA diet compared with the LF
diet. Also, fibrinogen concentrations increase after 3 weeks on
a high-MUFA diet compared with a low-fat–high-fibre
diet(19), and linoleic acid (PUFA) raises fibrinogen compared
with intake of SFA(20). Other studies find no effect on
fibrinogen, when comparing a MUFA diet with a SFA
diet(21), a PUFA diet(22) or a low-fat diet(23). Also, fat and
fibre quantity do not seem to influence fibrinogen(24,25). We
cannot exclude that the significantly higher body weight
in the MUFA group may partly explain the less favourable
fibrinogen effect of the MUFA diet.
The dietary effect on fibrinogen can be reinforced by the
observed reduction in D-dimer, which can release IL-6 from
monocytes and consequently affect the hepatic synthesis
of fibrinogen(26). Only a single dietary study has measured
D-dimer, with no differences in D-dimer between a high-
MUFA diet and a high-PUFA diet eaten for 4 weeks(22).
Most likely, lowering of D-dimer by all three dietary regimens
in the present study indicates that the controlled study in itself
had a healthy effect on the study participants, and that all three
experimental diets were healthier than the habitual diets eaten
by the overweight study participants. Alternatively, a decrease
over time can be caused by a seasonal variation, but there
seems to be only a minor variation in D-dimer, with maximum
values in February and March(27).
It seems unlikely that fibrinogen and D-dimer concen-
trations are lowered due to decreased coagulation activation,
as no significant changes were observed in FVII and F1 þ 2.
It was previously observed that low-fat–high-fibre diets
Table 3. Fasting concentrations of plasma variables before (0 months)
and after (6 months) dietary intervention with a high-MUFA diet (MUFA;
n 36), a low-fat diet (LF; n 40) or a control diet (n 23)
(Mean values and standard deviations)
0 months 6 months
Variable Mean SD Mean SD P ‡
BMI (kg/m2)
MUFA 28·42† 2·38 29·70*† 2·80 ,0·001
LF 26·97 2·09 27·68 2·36 ,0·001
Control 27·47 1·80 28·11 1·79 ,0·05
TAG (mmol/l)§
MUFA 0·93 1·48 0·82 1·48 0·12
LF 1·05 1·52 0·92 1·48 ,0·05
Control 1·05 1·46 0·96 1·46 0·15
Cholesterol (mmol/l)
MUFA 4·49 0·71 4·42 0·69 0·52
LF 4·52 0·93 4·52 1·04 0·98
Control 4·40 0·65 4·64 0·92 0·059
FVII:c (%)
MUFA 96 19 96 19 0·99
LF 96 23 97 24 0·86
Control 100 19 104 16 0·17
D-dimer (mg/ml)§
MUFA 0·27 1·61 0·21 1·51 ,0·05
LF 0·29 1·61 0·24 1·54 ,0·05
Control 0·30 1·66 0·27 1·78 0·056
PAI (ng/ml)§
MUFA 3·43 2·97 6·02 2·53 ,0·001
LF 3·47 2·51 5·01 2·35 ,0·01
Control 3·36 2·95 5·82 2·94 ,0·001
F1 þ 2 (pmol/l)§
MUFA 158·63 1·40 157·73 1·56 0·93
LF 157·31 1·32 153·06 1·45 0·45
Control 169·05 1·64 160·48 1·33 0·63
FVII:c, blood coagulation factor VII; PAI, plasminogen activator inhibitor; F1 þ 2,
prothrombin fragment 1 þ 2.
* Mean value was significantly different from that for control (P,0·05).
† Mean value was significantly different from that for LF (P,0·05).
‡ Mean values at 0 months and 6 months were compared with a paired t test within
diet groups. Between-diet comparisons at 0 months and 6 months were per-
formed with an ANOVA. When significant between-diet effects were observed,
pairwise comparisons were performed with the Bonferroni test.
§ D-dimer, PAI, F1 þ 2 and TAG were logarithmically transformed before analysis
(geometric mean and SD).
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Fig. 2. Effects of the high-MUFA diet (MUFA), the low-fat diet (LF) and the
control diet on (a) concentrations of fibrinogen (g/l) before (0 months; B) and
after 6 months (p) of dietary intervention and (b) changes in fibrinogen con-
centrations (g/l) during 6 months of dietary intervention (D fibrinogen 0! 6
months). Values are means, with standard errors represented by vertical
bars. Mean value was significantly different from that at 0 months: *P,0·05,
***P,0·001. Mean value was significantly different from that for LF:
†P,0·05, †† P,0·01.
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lower FVII:c compared with high-fat–low-fibre diets(24,25),
but the differences in amount of fat and fibre were larger
than in the present study. A high-MUFA diet lowers FVII:c
in some studies(19,22,28), whereas other highly controlled
studies cannot confirm the effect of fat quality on
FVII:c(21,29,30). Only a few dietary studies have included
measurements of F1 þ 2. Fat quality(30) and fibre quantity(22)
do not seem to influence F1 þ 2, but the type of saturated fat
may be of importance(31).
After an initial weight loss on the 8-week low-energy diet,
the study participants regained 2–3 kg during the 6-month
intervention study irrespective of diet(15). As expected,
the weight regain was accompanied by an increase in
PAI concentration in all groups irrespective of diet. In the
ANOVA, however, changes in BMI during 6 months
had no significant effect on changes in PAI, suggesting that
the minor weight regain was not a major determinant of
the increase in PAI. One explanation could be that the
observed increase in PAI is caused by seasonal variation.
Seasonal variation in PAI has been observed by Fro¨hlich
et al.(32), but with maximum concentration in March. Other
studies cannot confirm such a variation in PAI(24,33,34).
Whatever the reason for the increase in PAI during the
study period, the three experimental diets affected PAI to
a similar extent. Other studies have demonstrated that
MUFA-rich diets can reduce PAI activity or antigen compared
with low-fat or -SFA diets(23,35). Also, a low-GI diet can
reduce PAI activity or antigen compared with high-GI or
low-fat diets(12,36). Other studies found no effects of fat quality
and quantity on PAI concentrations(25,28,37).
Thus, many short-term studies have indicated that
MUFA-rich diets, low-fat–high-fibre diets, and diets with a
low GI have beneficial effects on selected haemostatic
variables. An exception is fibrinogen, which may be adversely
affected by high-MUFA diets. However, various conflicting
results have been reported. One major reason is that it is
extremely difficult to standardise dietary studies and to
completely control what individuals are eating. For the same
reason, only very few long-term controlled dietary studies
exist, and our randomised controlled long-term study adds
important information to our present knowledge.
Important strengths of the present study include the
randomised design, the long-term observation, the number of
subjects, and the highly controlled supermarket model
providing complex ad libitum diets for free-living individuals.
The haemostatic variables were not among the primary effect
variables in the power calculation (which was based on
changes in body weight)(18), but highly significant differences
were observed for PAI, D-dimer and fibrinogen, and there was
not even a trend towards differences in F1 þ 2 and FVII:c.
We cannot exclude that we were unable to detect a true
effect of the MUFA diet on fibrinogen due to a type 2 error,
which may also be the reason for the lack of significance
when comparing the three diets after 6 months (unpaired
design), or due to the significantly higher body weight
in the MUFA group. However, adjusting for baseline BMI
in the ANOVA makes the difference between fibrinogen
changes even more significant (P,0·01) (results not shown).
A limitation of the study is the weight regain in all three
dietary groups, which makes comparison with isoenergetic
dietary studies more difficult. Also, 3 weeks of standardisation
after the initial weight loss probably has a favourable effect on
the haemostatic variables, thereby lowering the true effects of
the experimental diets compared with the habitual diet in
overweight individuals. Unfortunately, no blood samples
were obtained at study start before weight loss, i.e. baseline
samples were obtained after the standardisation period.
Marckmann et al. have previously demonstrated a sustained
improvement in FVII:c, fibrinogen and PAI after a major
weight loss followed by a low-fat ad libitum maintenance
diet(38). However, the study aim was to compare the long-
term effect of three dietary regimens on haemostatic variables
during weight maintenance, and in relatively young subjects.
An older (and more atherosclerotic or insulin-resistant) study
population might have caused a greater difference in
haemostatic variables within and between the diets.
In conclusion, the MUFA diet was not superior to the LF
diet with respect to long-term effects on haemostatic variables
in overweight subjects after weight loss. Only the LF diet
lowered plasma fibrinogen, which is a well-documented
cardiovascular risk marker, and changes in fibrinogen
concentrations were affected significantly different between
diets, with the most favourable fibrinogen reduction on the
LF diet and no significant reduction on the MUFA diet.
All three diets had similar long-term effects on D-dimer
(favourable reductions) and PAI concentrations (disadvanta-
geous increments). No effects on thrombin generation were
observed. Thus, the thrombotic risk profile seems to be
improved most favourably by the LF diet compared with the
MUFA diet based on the reduction in fibrinogen
concentration.
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